RYTM - RHYTHM PHARMACEUTICALS, INC.

QQQ $ 634.81 $ 0.00 (0 %)

DIA $ 476.13 $ 0.00 (0 %)

SPY $ 685.72 $ 0.00 (0 %)

TLT $ 90.44 $ 0.00 (0 %)

GLD $ 370.28 $ 0.00 (0 %)

Previous Close

$ 111.81

Open

$ 113.33

Bid

$ 103.89 x 1

Ask

$ 116.47 x 2

Day's Range

-- - --

52 Week Range

$ 45.91 - $ 116.00

Volume

762,313

Average Volume

Market Cap

7.43B

Beta (5Y Monthly)

$ 1.45

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-01-2023	06-30-2023	10-Q
10	05-02-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-03-2022	06-30-2022	10-Q
14	05-03-2022	03-31-2022	10-Q
15	03-01-2022	12-31-2021	10-K
16	11-02-2021	09-30-2021	10-Q
17	08-03-2021	06-30-2021	10-Q
18	05-03-2021	03-31-2021	10-Q
19	03-01-2021	12-31-2020	10-K
20	11-02-2020	09-30-2020	10-Q
21	08-03-2020	06-30-2020	10-Q
22	05-04-2020	03-31-2020	10-Q
23	03-02-2020	12-31-2019	10-K
24	11-01-2019	09-30-2019	10-Q
25	07-29-2019	06-30-2019	10-Q
26	05-03-2019	03-31-2019	10-Q
27	03-08-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-08-2018	06-30-2018	10-Q
30	05-14-2018	03-31-2018	10-Q
31	03-12-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Goldman Sachs Maintains Buy on Rhythm Phar...
10/17/2025 17:21:28

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and lowers the price target ...

Morgan Stanley Maintains Overweight on Rhy...
10/16/2025 18:01:46

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and raises the price ta...

HC Wainwright & Co. Maintains Buy on Rhyth...
09/29/2025 10:31:24

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Buy and raises the...

Morgan Stanley Maintains Overweight on Rhy...
09/25/2025 17:54:10

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Overweight and raises the price t...

JMP Securities Maintains Market Outperform...
09/25/2025 13:13:08

JMP Securities analyst Jonathan Wolleben maintains Rhythm Pharmaceuticals (NASDAQ: RYTM) with a Market Outperform and raises...

Goldman Sachs Maintains Buy on Rhythm Phar...
09/24/2025 18:01:13

Goldman Sachs analyst Corinne Jenkins maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target ...

Peering Into Rhythm Pharmaceuticals's Rece...
09/11/2025 17:01:03

Rhythm Pharmaceuticals Announces The FDA H...
08/20/2025 20:03:53

U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 --– E...

HC Wainwright & Co. Maintains Buy on Rhyth...
08/07/2025 11:58:45

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the ...

12 Analysts Have This To Say About Rhythm ...
08/06/2025 21:04:06

Morgan Stanley Maintains Overweight on Rhy...
08/06/2025 16:30:58

Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and raises the price ta...

JMP Securities Maintains Market Outperform...
08/06/2025 15:19:13

JMP Securities analyst Jonathan Wolleben maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Market Outperform and raises ...

Guggenheim Maintains Buy on Rhythm Pharmac...
08/06/2025 14:56:41

Guggenheim analyst Seamus Fernandez maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target fr...

Rhythm Pharmaceuticals Q2 EPS $(0.75) Miss...
08/05/2025 11:03:46

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate...

Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

A Glimpse Into The Expert Outlook On Rhyth...
07/18/2025 18:00:39

Canaccord Genuity Maintains Buy on Rhythm ...
07/18/2025 14:14:51

Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and raises the price target...

Reported Saturday, Rhythm Pharmaceuticals ...
07/14/2025 06:51:46

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –- Full data fro...

Leerink Partners Maintains Outperform on R...
07/10/2025 20:41:15

Leerink Partners analyst Faisal Khurshid maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform and raises the pri...

Oppenheimer Maintains Outperform on Rhythm...
07/10/2025 18:02:10

Oppenheimer analyst Leland Gershell maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform and raises the price ta...